You have 9 free searches left this month | for more free features.

Ethambutol

Showing 26 - 50 of 201

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

Active, not recruiting
  • MDR-TB
  • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
  • +9 more
  • Addis Ababa, Ethiopia
  • +12 more
Oct 12, 2022

Cystic Fibrosis Trial in Aurora (Ethambutol, Rifampin, Azithromycin)

Completed
  • Cystic Fibrosis
  • Ethambutol
  • +3 more
  • Aurora, Colorado
    Children's Hospital Colroado
Jan 20, 2021

Mycobacterium Avium-intracellulare Infection, HIV Trial in United States (Ethambutol HCl, Clarithromycin, Clofazimine)

Completed
  • Mycobacterium Avium-intracellulare Infection
  • HIV Infections
  • Ethambutol hydrochloride
  • +3 more
  • San Francisco, California
  • +15 more
Oct 28, 2021

HIV, Tuberculosis Trial in United States (Ethambutol HCl, Isoniazid, Pyrazinamide)

Completed
  • HIV Infections
  • Tuberculosis
  • Ethambutol hydrochloride
  • +5 more
  • Los Angeles, California
  • +11 more
Oct 28, 2021

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)

Not yet recruiting
  • Pulmonary Tuberculosis
  • Rifampicin-resistant Tuberculosis
  • Beijing, Beijing, China
  • +37 more
Oct 11, 2023

Pulmonary Disease Due to Mycobacteria (Diagnosis) Trial in Worldwide (Amikacin, Tigecycline, Imipenem)

Recruiting
  • Pulmonary Disease Due to Mycobacteria (Diagnosis)
  • South Brisbane, Queensland, Australia
  • +36 more
Sep 12, 2022

d to Treat Drug Sensitive Tuberculosis in Breastfeeding

Recruiting
  • Tuberculosis Active
  • +2 more
  • First line tuberculosis treatment
  • Kampala, Uganda
    Infectious Diseases Institute
Apr 22, 2023

Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

Recruiting
  • Mycobacterium Infections, Nontuberculous
  • Birmingham, Alabama
  • +172 more
Jan 23, 2023

Mycobacterium Avium-intracellulare Infection, HIV Trial in Tanzania, United States (Indinavir sulfate, Ritonavir, Ethambutol

Completed
  • Mycobacterium Avium-intracellulare Infection
  • HIV Infections
  • Indinavir sulfate
  • +4 more
  • Birmingham, Alabama
  • +33 more
Oct 28, 2021

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Efficacy and Safety of Intravenous Treatment of Tuberculosis

Terminated
  • Tuberculosis, Pulmonary
  • Chernivtsi, Ukraine
  • +8 more
Nov 4, 2019

Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis Trial in Worldwide (TBAJ-876, Pretomanid, Linezolid)

Not yet recruiting
  • Pulmonary TB
  • +2 more
  • Tbilisi, Georgia
  • +20 more
Sep 22, 2023

Tuberculosis, Meningeal, Linezolid Trial in Bandung (Linezolid)

Recruiting
  • Tuberculosis, Meningeal
  • Linezolid
  • Bandung, Jawa Barat, Indonesia
    Hasan Sadikin General Hospital
Aug 7, 2022

HIV-1 Infection Trial in Worldwide (Xpert MTB/RIF®, Determine TB LAM, Chest X-ray, ART (Atripla, Truvada, Efavirenz, Combivir),

Completed
  • HIV-1 Infection
  • Xpert MTB/RIF®, Determine TB LAM, Chest X-ray
  • +2 more
  • Phnom Penh, Cambodia
  • +3 more
Oct 13, 2020

Tuberculosis, Pulmonary Trial (Cephalexin, Amoxicillin-Clavulanate 500 Mg-125 Mg Oral Tablet, Standard of care treatment of

Not yet recruiting
  • Tuberculosis, Pulmonary
  • (no location specified)
Dec 15, 2022

Sarcoidosis; Antimycobacterial Therapy Trial in United States (Levofloxacin, Ethambutol, Azithromycin)

Completed
  • Sarcoidosis; Antimycobacterial Therapy
  • Albany, New York
  • +5 more
Jul 7, 2020

Tuberculosis Trial in Shanghai, Hangzhou (Short-course regimen, Standard regimen)

Active, not recruiting
  • Tuberculosis
  • Short-course regimen
  • Standard regimen
  • Shanghai, Shanghai, China
  • +1 more
Nov 22, 2023

Pulmonary Tuberculosis Trial in Zhuhai (Moxifloxacin, Isoniazid, Rifampicin, Rifampicin,Isoniazid,Pyrazinamide,Ethambutol)

Not yet recruiting
  • Pulmonary Tuberculosis
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital Sun Yat-Sen University
Dec 4, 2019

HIV, Tuberculosis Trial in United States (Cycloserine, Ethionamide, Capreomycin sulfate)

Completed
  • HIV Infections
  • Tuberculosis
  • Chicago, Illinois
  • +20 more
Oct 27, 2021

Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

Active, not recruiting
  • Mycobacterium Infections, Nontuberculous
  • Birmingham, Alabama
  • +110 more
Jan 23, 2023

HIV Infection Trial in Worldwide (Atripla (r), Efavirenz, Truvada)

Completed
  • HIV Infection
  • Atripla (r)
  • +5 more
  • Rio de Janeiro,, Brazil
  • +17 more
Jan 8, 2021

Tuberculosis, Pulmonary Trial in Seoul (High-dose rifampicin, Isoniazid, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • High-dose rifampicin
  • +4 more
  • Seoul, Korea, Republic of
    Division of Pulmonology and Critical Care Medicine, Department o
Jul 21, 2020

Tuberculosis Trial in Worldwide (rifapentine, rifapentine and moxifloxacin, control)

Completed
  • Tuberculosis
  • San Francisco, California
  • +32 more
Sep 1, 2021

Tuberculosis Trial in Johannesburg (Pravastatin)

Completed
  • Tuberculosis
  • Johannesburg, South Africa
    Chris Hani Baragwanath Hospital
Sep 26, 2022

Tuberculosis, Multidrug Resistant Tuberculosis Trial in Paris (Tedizolid arm (SIVEXTRO®), Linezolid arm (ZYVOXID®), Standard

Not yet recruiting
  • Tuberculosis
  • Multidrug Resistant Tuberculosis
  • Tedizolid arm (SIVEXTRO®)
  • +2 more
  • Paris, France
    Bacteriology department- Hôpital Saint-Antoine
Sep 6, 2022